Pharmacy

More access to this life-saving medication is essential

Lack of data from hospitals, PBMs in the spotlight at hearing

Agency reviewers recommend monovalent shot for 2023-2024 booster campaign

"I wouldn't prescribe it to an otherwise healthy person," researcher says

After widespread use for more than a year, Paxlovid gains full agency blessing

House committee hearing focuses on the best way to rein in high drug prices

Also in TTHealthWatch: a peanut allergy patch for young children and orphan drug profits

This "is a moral issue," Sen. Bernie Sanders said during the hearing

They may be able to offer cheap generics, but most drug spending is on branded products

The suffering caused by exorbitant drug prices is all too clear for doctors to see

High court reviews lower court ruling focused on "subjective intent"

This past week in healthcare investigations

A look at Horizon Therapeutics' tactics

Youth need broader access to non-pharmaceutical interventions from trained professionals